Hans K Hasselbalch

Hans K Hasselbalch serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Internal Medicine: Haematology. His clinical and research activities are centered at Køgevej 7-13, Roskilde (4000) and Blegdamsvej 3, Copenhagen N (2200), with direct contact via +4547323200 and hkhl@regionsjaelland.dk.

His research focuses on the intersection of hematologic malignancies and systemic complications, particularly investigating myeloproliferative neoplasms (MPNs), clonal hematopoiesis (CHIP), and JAK2 V617F mutation pathophysiology. Key themes include thromboinflammation mechanisms, cardiovascular and cerebrovascular complications, dementia risk associations, and ocular manifestations in blood disorders. His work employs population-based cohort studies, molecular profiling, and multicenter clinical collaborations to unravel disease mechanisms and therapeutic implications.

Analysis of his recent publications reveals a strong emphasis on translational research connecting somatic mutations to multi-organ pathologies. His team actively investigates how CHIP mutations drive inflammation-mediated tissue damage across vascular, neural, and ocular systems, with significant implications for risk stratification and targeted interventions.

Hasselbalch maintains extensive national and international collaborations, evidenced by co-authorship across diverse institutions in cardiovascular, neurological, and ophthalmological research. His work has garnered attention across social media (13+ X posts), academic platforms (19+ Mendeley readers), and news outlets, with one publication referenced in Wikipedia.